Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1990 Jul;86(1):196-202.
doi: 10.1172/JCI114684.

Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b

Affiliations
Case Reports

Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b

L Kilpatrick et al. J Clin Invest. 1990 Jul.

Abstract

Patients with glycogen storage disease (GSD) type 1b (1b), in contrast to patients with GSD type 1a (1a), are susceptible to recurrent bacterial infections suggesting an impairment in their immune system. In this study, phagocytic cell (neutrophil and monocyte) respiratory burst activity, as measured by superoxide anion generation, oxygen consumption, and hexose monophosphate shunt activity, was markedly reduced in both neutrophils and monocytes from GSD 1b patients as compared with either GSD 1a patients or healthy adult control cells. Degranulation, unlike respiratory burst activity, was not significantly different in neutrophils from GSD 1b patients as compared with controls. Both neutrophils and monocytes from GSD 1b patients showed decreased ability to elevate cytosolic calcium in response to the chemotactic peptide f-Met-Leu-Phe. In addition, calcium mobilization in response to ionomycin was also attenuated suggesting decreased calcium stores. Thus, reduced phagocytic cell function in GSD 1b is associated with diminished calcium mobilization and defective calcium stores. Defective calcium signaling is associated with a selective defect in respiratory burst activity but not degranulation.

PubMed Disclaimer

References

    1. J Clin Invest. 1967 Apr;46(4):668-79 - PubMed
    1. J Biol Chem. 1952 Dec;199(2):661-7 - PubMed
    1. N Engl J Med. 1968 Oct 31;279(18):958-65 - PubMed
    1. J Biol Chem. 1970 Nov 25;245(22):6228-34 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3818-22 - PubMed

Publication types